Sorrento Therapeutics, Inc. (NASDAQ:SRNE – Get Free Report)’s share price crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $0.00 and traded as high as $0.0020. Sorrento Therapeutics shares last traded at $0.0011, with a volume of 334,705 shares.
Sorrento Therapeutics Trading Down 53.3%
The company has a market capitalization of $385,896.00, a PE ratio of -0.00 and a beta of 0.10.
Sorrento Therapeutics Company Profile
Sorrento Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the development of therapies in immuno-oncology, inflammatory diseases and pain management. Leveraging proprietary antibody, small molecule and cell therapy platforms, Sorrento aims to advance next-generation treatment candidates that address unmet medical needs in oncology and chronic pain without reliance on traditional opioids.
The company’s immuno-oncology pipeline encompasses monoclonal antibodies, antibody-drug conjugates and engineered cell therapies designed to target solid tumors and hematologic malignancies.
Featured Stories
- Five stocks we like better than Sorrento Therapeutics
- AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target
- Micron’s $250 Billion Bet Could Reshape the AI Memory Race
- Rocket Lab’s Stock Drop Comes With a Bullish Twist
- Amazon’s New Debt Deal Puts Its AI Spending Story on Trial
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
